For example, mutations at the PKD-1 locus are associated with a higher likelihood of CKD progression compared with PKD-2 [18], and it could be hypothesised that there was a higher proportion of PKD-1 mutations in the group with the lower eGFR. The gene discussed is PKD1; the disease is polycystic kidney disease 2.